statement represents net gain of Baht 21.83 million, which increased by Baht 106.24 million or 125.86%. The separated statement represents net gain of Baht 23.59 million which increased by Baht 109.37 million
0.29 3.08 Net profit (loss) (0.07) 0.19 11.58 * Other income included revenue from sales of finished products, packages, packaging services, interest income and gain on disposal of assets. Statements of
income included revenue from sales of finished products, packages, packaging services, interest income and gain on disposal of assets. บริษัท ดีโอดี ไบโอเทค จ ำกัด (มหำชน) 111 หมู่ท่ี 2 ต ำบลท่ำจนี อ ำเภอ
overall business structure of the majority shareholder. Also required is information on the rationale and opportunity or necessity for mutual reliance and support as well as strategic positioning of the
operate by itself instead of rent out. 1.5) Other Revenue decrease THB 16.13 million due from Gain from disposal of assets decrease THB 12.83 million because of in the year 2016 the Company had gain on
/- Decreased /-Decreased Brokerage fees income 914.15 (135.35) 914.15 (135.35) Fees and service income 81.40 (12.81) 81.40 (12.81) Interest income on margin loans 55.25 (12.43) 55.25 (12.43) Gain (loss) and
additional changes to existing projects and maintenance projects that was completed the previous year. Some of contracts cost had been recognized last year. Another contributing factor is the gain from change
178.76 109.66 Revenue from sales electricity 93.21 92.22 Revenue from sales and services 4.10 3.45 Gain on investments 8.62 1.28 Gain on exchange rate 67.04 - Other income 5.79 12.71 EXPENSES (115.93
) Gross profit 439.4 427.9 11.5 2.7 Net gain on exchange rate 55.1 112.2 (57.1) (50.9) Gain on forward contracts 11.2 49.5 (38.3) (77.4) Other income 2.0 173.0 (171.0) (98.8) Profit before expenses 507.7
holders (Exclude Gain (Loss) on exchange rate) 426 127 299 236.2% Net profit (loss) attributable to equity holders Margin (%) (Exclude Gain (Loss) on exchange rate) 5.8% 2.9% 2.8% EBITDA 1,036 600 436 72.7